259 related articles for article (PubMed ID: 4154740)
21. Potential value of penfluridol and pipothiazine palmitate.
Gallant DM
Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
[No Abstract] [Full Text] [Related]
22. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
Richou H
Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
[No Abstract] [Full Text] [Related]
23. [Drug therapy of paranoid psychoses].
Robak OH
Tidsskr Nor Laegeforen; 1978 Jun; 98(16):852-4. PubMed ID: 675631
[No Abstract] [Full Text] [Related]
24. [Clinical experience with the neuroleptic 19.366 R.P. (pipothiazine)].
Arrojo Lois M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):309-12. PubMed ID: 31067
[No Abstract] [Full Text] [Related]
25. [Experiences with depot form flupenthixol].
Bruck J; Guss H
Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657
[No Abstract] [Full Text] [Related]
26. Clinical experience with fluspirilene in psychoses.
Svestka J; Náhunek K; Hádlík J; Rodová A
Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825
[No Abstract] [Full Text] [Related]
27. General evaluation of pipotiazine palmitate (19.552 R.P.) in hospitalized schizophrenic patients.
Gerlach J; Nyeborg O; Prieto R
Acta Psychiatr Scand Suppl; 1973; 241():69-74. PubMed ID: 4147513
[No Abstract] [Full Text] [Related]
28. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
López-Ibor Aliño JM
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
[No Abstract] [Full Text] [Related]
29. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
Tanghe A; Vereecken JL
Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
[No Abstract] [Full Text] [Related]
30. Depot pipotiazine 1970-1982: a review.
Burch EA; Ayd FJ
J Clin Psychiatry; 1983 Jul; 44(7):242-7. PubMed ID: 6134718
[TBL] [Abstract][Full Text] [Related]
31. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
32. A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
Astrup C; Grimgård A; Hebnes K; Kruse-Jensen A; Lid M
Acta Psychiatr Scand; 1974; 50(5):481-91. PubMed ID: 4156624
[No Abstract] [Full Text] [Related]
33. [7 years of experience with delayed action neuroleptics].
Noguera Hosta R; Rendueles de Olmedo G
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
[No Abstract] [Full Text] [Related]
34. [Clinical trial of delayed-action Akinophyl (Akineton)].
Delteil P; Decreton C
Ann Med Psychol (Paris); 1972 May; 1(5):696-709. PubMed ID: 5081113
[No Abstract] [Full Text] [Related]
35. Psychological medicine. Schizophrenia and related paranoid psychoses.
Kennedy PF
Br Med J; 1975 May; 2(5965):257-60. PubMed ID: 236808
[No Abstract] [Full Text] [Related]
36. Tardive dyskinesia: side effect or not?
Curran JP
Am J Psychiatry; 1973 Apr; 130(4):406-10. PubMed ID: 4144163
[No Abstract] [Full Text] [Related]
37. [Prolonged action neuroleptics (review of the foreign literature)].
Obukhov GA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
[No Abstract] [Full Text] [Related]
38. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
39. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
[TBL] [Abstract][Full Text] [Related]
40. Central atropine-like toxicity in combined psychotropic drug administration.
el-Yousef MK; Davis JM; Janowsky DS; Fann WE
J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
